Last reviewed · How we verify
NCT06920537
Postpartum CO Rehabilitation
NA trial testing Postpartum Cardio-obstetric Rehabilitation Program in Gestational Hypertension in 40 participants. Not yet recruiting.
30 August 2026
Quick facts
| Lead sponsor | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 15 June 2025 |
| Primary completion | 30 August 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Postpartum Cardio-obstetric Rehabilitation Program
Conditions studied
- Gestational Hypertension — all drugs for Gestational Hypertension →
- Preeclampsia (PE) — all drugs for Preeclampsia (PE) →
Sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal — full company profile →
Who can join
18 and older, female only, with Gestational Hypertension or Preeclampsia (PE). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some women who develop high blood pressure during pregnancy, such as gestational hypertension or preeclampsia, may continue to have slightly or moderately high blood pressure after giving birth. This can increase their risk of heart disease later in life. Managing blood pressure and adopting a healthy lifestyle after pregnancy could help lower this risk. Right now, the investigators don't know much about how postpartum rehabilitation programs focused on heart and pregnancy-related health could help women with these conditions. However, a feasibility study suggests that exercise programs might help reduce blood pressure and encourage healthier lifestyles in these women. In this study, the investigators are testing an 8-week exercise program to see how it affects blood pressure, fitness, and blood vessel health. The investigators will compare the results with a group of women who receive usual healthcare, which includes verbal advice on healthy living but no supervised exercise sessions. This type of program, called cardio-obstetric rehabilitation, combines exercises for heart health with specialized care for women's health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06920537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Hypertension
Currently open trials in the same condition.
- NCT06953115 — Vagal Stimulation Therapy and Preeclampsia · NA · recruiting
- NCT07041281 — Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories · Phase 2 · recruiting
- NCT07349277 — Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Pree · recruiting
- NCT06632379 — AtorvaStatin Postpartum and Reduction of Cardiovascular risK · Phase 4 · recruiting
- NCT06814509 — Delivering HOPE (Helping Women Optimize Prenatal Equity) · NA · recruiting
Other Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal trials
Trials by the same sponsor.
- NCT07508514 — Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA · not yet recruiting
- NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
- NCT06971315 — Impact of Vitamin C on Pain Detection and Tolerance Threshold · NA · completed
- NCT06120608 — Evidence for Potassium Restriction in Hemodialysis · NA · active not recruiting
- NCT06620393 — Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06920537 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06920537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing